Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical).
Weight loss, HbA1c reduction and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics : comparison with orlistat (Xenical).